RGNX 7.62 (+2.83%)
US75901B1070BiotechnologyBiotechnology

Regenxbio (RGNX) Financial Metrics

This table shows a selected set of financial data points of Regenxbio (RGNX). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -6.02 0 -2.98 785.03M -0.37 90.24M -228.37M -250.78M -263.49M 34.52M
2022 -6.5 0 -3.49 978.69M -0.29 112.72M -238.21M -249.63M -280.32M 96.95M
2021 3.01 0 10.86 1.39B 0.14 470.35M 134.7M 170.26M 127.84M 345.21M
2020 -2.98 0 -15.2 1.69B -0.18 154.57M -80.93M -106.56M -111.25M 338.43M
2019 -2.58 0 -15.87 1.5B -0.18 35.23M -119.43M -197.56M -94.73M 69.51M
2018 2.73 0 15.38 1.54B 0.27 218.51M 91.37M 92.08M 99.94M 75.56M
2017 -2.45 0 -13.58 993.44M -0.39 10.39M -65.15M -73.2M -73.17M 46.66M
2016 -2.38 0 -7.78 489.89M 0 4.59M -56.71M 0 -62.97M 24.84M
2015 0 0 0 152.27M 0 0 -23.04M 0 0 0
2014 0 0 0 0 0 0 -2.4M 0 0 0
2013 0 0 0 0 0 0 -3.01M 0 0 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.